Loading insider details...
Beta
Latest Form 4 (Aug 12, 2026): Sale of 2,655 AVTX shares, $52.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 12, 2026 | Avalo Therapeutics, Inc. (AVTX) | Sale | 2,655 | $52.0K |
| Jun 12, 2026 | Avalo Therapeutics, Inc. (AVTX) | Tax Withholding | 588 | $7.7K |
| May 26, 2026 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 34,200 | n/a |
| Mar 2, 2026 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 95,000 | n/a |
| Dec 12, 2025 | Avalo Therapeutics, Inc. (AVTX) | Tax Withholding | 637 | $2.6K |
| Jan 3, 2025 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 150,000 | n/a |